(444 days)
K191422, Neural Navigator
No
The summary describes a 3D navigation system for TMS coil positioning based on MRI data or scalp landmarks and optional EMG. It focuses on hardware components, compatibility, and performance metrics related to accuracy and safety. There is no mention of AI, ML, or related concepts like training/test sets, which are typically included in summaries for devices utilizing these technologies.
No.
The device is a 3D navigation system that aids in positioning TMS coils, but it does not directly provide therapy. It is used to guide the placement of therapeutic devices (TMS coils) which are separately cleared by the FDA.
No.
The device is a 3D navigation system that aids in positioning TMS coils. While it uses MRI data and can optionally record EMG signals to guide placement, its primary function is for navigation and positioning, not for diagnosing a disease or condition. The text also states it is "used to aid 3D navigation", which indicates a supportive rather than a diagnostic role.
No
The device description explicitly states that the visor2 system consists of hardware components including a cart, an All-in-One medical computer, a mounting plate, and a Tracking camera with mounting arm.
Based on the provided information, the visor2 device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- visor2 Function: The visor2 system is a 3D navigation system used to guide the positioning of Transcranial Magnetic Stimulation (TMS) coils over the brain. It uses MRI data or scalp landmarks and optionally EMG recording.
- No Specimen Analysis: The description of the visor2 system does not involve the analysis of any specimens taken from the human body. Its function is entirely focused on external navigation and positioning of a separate medical device (TMS coil) on the patient's head.
Therefore, the visor2 device falls under the category of a medical device used for guiding a therapeutic procedure, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
visor2 is used to aid 3D navigation for positioning of Transcranial Magnetic Stimulation (TMS) coils over preselected brain regions based on data from MRI measurements or scalp landmarks and optional EMG recording in clinical procedures. The visor2 system is compatible with the following commercially available TMS coils of the following TMS companies:
- · Mag & More: PMD70-aCool Double coil Figure-8 (510575)
- MagStim Company Ltd.: Double 70mm Remote Coil (3190-00 rev2), Double 70mm Air Film Coil (3910 00);
- MagVenture A/S: Double 75mm (C-B60), Double Cooled 75mm (Cool-B65), Double 95mm (D-B80), Angulated Double Cooled 97mm (Cool-B70 rev2), Butterfly figure-8 (C-B70)
- · Neuronetics Inc .: NeuroStar coil
The visor2 system must be operated by a trained physician and must not be used during surgical operations.
Product codes (comma separated list FDA assigned to the subject device)
HAW, GWF, IKN, OBP
Device Description
The visor2 system is a 3D navigation system, supporting external/surface positioning of labeling identified commercially available Transcranial Magnetic Stimulation (TMS) coils based on the anatomical and functional areas for which use of the coil has been FDA cleared and as identified in cleared labeling for the coil. The visor2 system optionally records and processes electrophysiological signals to guide the user in the TMS coil placement. The visor2 system is compatible with TMS stimulators identified in the labeling that meet IEC 60601-1 and IEC 60601-1-2 electrical safety and EMC standards, a compatible optical tracking system, and further compatible accessories. Optionally, a compatible amplifier identified in the labeling may be applied for measuring electrophysiological signals. The visor2 system must be operated by a trained physician, and must not be used during surgical operations.
The visor2 system consists of a cart, an All-in-One medical computer with touch interface, a mounting plate for an optional amplifier applied for EMG recording and a Tracking camera with mounting arm. There are two fundamental visor2 system variants: single or dual display. the second configuration is available with an additional touch display added next to the All-in-One computer. Both variants are identical with regard to hardware features.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
MRI measurements
Anatomical Site
brain regions
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained physician / clinical procedures
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical Performance Tests to Demonstrate Substantial Equivalency:
- Test: Electrical Safety
- Test Method Summary: IEC 60601-1:2005 (Third Edition) + CORR. 1:2006 + CORR. 2:2007 +A1:2012
- Result: Pass
- Test: Electromagnetic Compatibility
- Test Method Summary: IEC 60601-1-2 Edition 4.0 2014-02
- Result: Pass
- Test: The visor2 system under review is an accessory to Repetitive Transcranial Magnetic Stimulation (TMS) systems.
- Test Method Summary: Review and document compliance with Class II Special Controls guidance document: Repetitive Transcranial Magnetic Stimulation Systems, issued July 26, 2011
- Result: Pass
- Test: System performance to specifications
- Test Method Summary: Hardware, software and system evaluations.
- Result: Pass
- Test: Biocompatibility evaluation
- Test Method Summary: The Pointer Tool is the only supplied patient contacting component of the visor2 system. The patient contact materials in their final finished form, are identical to the StimGuide TMS coil location/navigation feature in K183376.
- Result: Pass
- Test: Software verification, validation
- Test Method Summary: The visor2 system software was developed and documentation provided in compliance with the FDA Guidance document: Guidance for the Content of Premarket Submissions for Software Content in Medical Devices, May 11, 2005. Intentional and unintentional cybersecurity risks and mitigations are applied.
- Result: Pass
Performance Testing Summary:
- Test: Commercial TMS Coil compatibility
- Test Method Summary: Validation testing is used with users that use respective coils covering the workflow on confirming expected accuracy.
- Results: Pass. The compatible commercially compatible TMS coils are demonstrated to be able to be calibrated and properly applied within the location accuracy defined by the visor2 system.
- Test: Over all accuracy of TMS coil position relative to the head (absolute value)
- Test Method Summary: Worst case upper limit of the position mismatch in positioning the coil relative to the head.
- Results: Pass, Range less than or equal to 10 mm
- Test: Position accuracy (Tracking camera)
- Test Method Summary: Volumetric Accuracy: based on a single marker stepped through more than 900 positions throughout the measurement volume using the mean of 30 samples at each position at 20°C.
- Results: Main PASS criteria: The stimulus position should be within 4mm of the physical setup and the distance between stimulus target and stimulus below 2mm.
- Test: Navigation Principle
- Test Method Summary: Same as the main accuracy test that covers all aspects of the main navigation principle. Further to this it is checked that the distance between target and stimulus can be reduced to 2mm. Main navigation principle is 'point based registration' between MRI space and patient space, and the calibration of navigation tools. It is tested via a comparison of known nominal positions/rotations in the physical world with tracked coil positions to covers all relevant tolerances and deviations in tools and other mechanical structures.
- Results: Main PASS criteria: Accuracy limit in validation workflow 4mm
- Test: Coil Compatibility
- Test Method Summary: Covered by the general test as each coil is registered by the user as part of the workflow. Coil mount fixated on the TMS coil handle. Coil tracker mount firmly attached. Coil tracker calibrated to coil dimensions via calibration board. Tracking tools material composition: Polyurethane (PUR).
- Results: Passed validation
- Test: Coil Compatibility - Validation
- Test Method Summary: The user is guided through the coil calibration and tracking steps and a questionnaire is used to trace the validation content and result. Validation reports for specific coils as listed in indications for use. Testing of coil calibration & validation in physical setup, robust with camera movement.
- Results: Declaration of Conformity by Northern Digital Inc. and over-all system accuracy better than 4mm
- Test: Tracking System Accuracy
- Test Method Summary: Compatible camera Northern Digital Inc. (NDI) (refer to system components defined in user guide). Main relevant tests covering this aspect: In this test a coil / coil-tracking-tool is placed at known nominal positions with fully constraint orientation and measured against a ground truth in the physical scene. This covers all tolerances summing up when using the system including initial nasion-ear and coil registration steps.
- Results: The match between positions and length in over-all system accuracy better than 4mm
- Test: System Accuracy
- Test Method Summary: Same as tracking system accuracy. The tracking accuracy testing covers all tolerances summing up when using the system including initial nasion-ear and coil registration steps.
- Results: Main criteria: Accuracy of landmarks to MRI within 2mm.
- Test: Imaging Modality
- Test Method Summary: MRI image with known landmark positions is loaded and positions of them are checked in the render 3D scene against the ground truth. MRI image with known landmark positions is loaded and positions of them are checked in the render 3D scene against the ground truth.
- Results: 10% accuracy in EMG parameters for functional mapping. Over-all position system accuracy better than 4mm.
- Test: Selection of targets via anatomical and functional landmarks
- Test Method Summary: Visor2 follows the same scheme as reference HORIZON TMS Therapy System with Navigation and defines targets via anatomical or functional landmarks. The latter uses EMG. The EMG test is done by applying a known function to the input of the patient leads and making sure the waveform in visor2 follows the ground truth applied with the defined accuracy. For navigation again the overall accuracy test for the system is applied and needs to pass.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K191422, Neural Navigator
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K183376, HORIZON TMS Therapy System with Navigation, K112881, Nexstim Navigational Brain Stimulation (NBS) System 4, Nexstim NBS System 4 with NEXSPEECH®
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
April 8, 2022
Eemagine Medical Imaging Solutions GmbH % Gary Syring Principal Consultant Quality & Regulatory Associates, LLC 800 Levanger Lane Stoughton, Wisconsin 53589
Re: K210109
Trade/Device Name: visor2 system Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: HAW, GWF, IKN, OBP Dated: March 9, 2022 Received: March 11, 2022
Dear Gary Syring:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Pamela Scott Assistant Director DHT5B: Division of Neuromodulation and Physical Medicine Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
510(k) Number (if known) K210109
Device Name visor2 system
Indications for Use (Describe)
visor2 is used to aid 3D navigation for positioning of Transcranial Magnetic Stimulation (TMS) coils over preselected brain regions based on data from MRI measurements or scalp landmarks and optional EMG recording in clinical procedures. The visor2 system is compatible with the following commercially available TMS coils of the following TMS companies:
- · Mag & More: PMD70-aCool Double coil Figure-8 (510575)
- MagStim Company Ltd.: Double 70mm Remote Coil (3190-00 rev2), Double 70mm Air Film Coil (3910 00);
- MagVenture A/S: Double 75mm (C-B60), Double Cooled 75mm (Cool-B65), Double 95mm (D-B80), Angulated Double Cooled 97mm (Cool-B70 rev2), Butterfly figure-8 (C-B70)
- · Neuronetics Inc .: NeuroStar coil
The visor2 system must be operated by a trained physician and must not be used during surgical operations.
Type of Use (Select one or both, as applicable) | |
---|---|
Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
RAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for eemagine medical imaging solutions. The word "eemagine" is written in gray, with the words "medical imaging solutions" written in a smaller font below it. To the right of the word "eemagine" are two blue circles with the letter "e" inside them. A blue line connects the two circles, resembling an EKG readout.
eemagine Medical Imaging Solutions GmbH, Gubener Str. 47, D-10243 Berlin
510(k) Summary | Date |
---|---|
This summary is provided to support the 510(k) pre-market notification for the visor2 | |
system. | Berlin |
Company Name: eemagine | Reference (eemagine): |
e.g. contract ID | |
Company Contact: Frank Zanow, Chief Executive Officer | |
eemagine Medical Imaging Solutions GmbH | |
Date Summary Prepared: April 8, 2022 | eemagine GmbH |
Gubener Str.47 | |
D-10243 Berlin | |
Tel. +49 30 29048404 | |
Fax. +49 30 29048405 | |
www.eemagine.com | |
Trade Name: visor2 system | |
Common Name: Accessory to Repetitive Transcranial Magnetic Stimulation | |
Classification Name: Repetitive Transcranial Magnetic Stimulation System | |
21 CFR 882.4560, Product Code: HAW, Class II | |
Primary Predicate: K191422, Neural Navigator | |
Manufacturer: Soterix Medical, Inc., New York, NY 10001 | CEO/Geschäftsführer: |
Ralf Hauffe, Ph.D. | |
Reference Devices: K183376, HORIZON TMS Therapy System with Navigation | |
Manufacturer: Magstim Company Ltd., Whitland, GB Sa34 0hr | Registration: HRB 7128 |
VAT ID: DE201608185 | |
K112881, Nexstim Navigational Brain Stimulation (NBS) | |
System 4, Nexstim NBS System 4 with NEXSPEECH® | |
Manufacturer: NEXSTIM OY, Helsinki, FI-00510 | Commerzbank Berlin |
BIC Code CoBaDEBB120 | |
IBAN |
DE73120400000458888500
Product Description
The visor2 system is a 3D navigation system, supporting external/surface positioning of labeling identified commercially available Transcranial Magnetic Stimulation (TMS) coils based on the anatomical and functional areas for which use of the coil has been FDA cleared and as identified in cleared labeling for the coil. The visor2 system optionally records and processes electrophysiological signals to guide the user in the TMS coil placement. The visor2 system is compatible with TMS stimulators identified in the labeling that meet IEC 60601-1 and IEC 60601-1-2 electrical safety and EMC standards, a compatible optical tracking system, and further compatible accessories. Optionally, a compatible amplifier identified in the labeling may be applied for measuring electrophysiological signals. The visor2 system must be operated by a trained physician, and must not be used during surgical operations.
The visor2 system consists of a cart, an All-in-One medical computer with touch interface, a mounting plate for an optional amplifier applied for EMG recording and a Tracking camera with mounting arm. There are two fundamental visor2 system variants: single or dual display. the second configuration is available with an additional touch display added next to the All-in-One computer. Both variants are identical with regard to hardware features.
4
Indications for Use
visor2 is used to aid 3D navigation for positioning of Transcranial Magnetic Stimulation (TMS) coils over preselected brain regions based on data from MRI measurements or scalp landmarks and optional EMG recording in clinical procedures. The visor2 system is compatible with the following commercially available TMS coils of the following TMS companies:
- · Mag & More: PMD70-aCool Double coil Figure-8 (510575)
- MagStim Company Ltd.: Double 70mm Remote Coil (3190-00 rev2), Double 70mm Air Film Coil (3910 00);
- MagVenture A/S: Double 75mm (C-B60), Double Cooled 75mm (Cool-B65), Double 95mm (D-B80), Angulated Double Cooled 97mm (Cool-B70 rev2), Butterfly figure-8 (C-B70)
- · Neuronetics Inc.: NeuroStar coil
The visor2 system must be operated by a trained physician and must not be used during surgical operations.
Substantial Equivalence Technical Characteristics | |||||
---|---|---|---|---|---|
Feature | Subject Device | ||||
visor2 system | Primary | ||||
Predicate | |||||
Neural | |||||
Navigator | |||||
(K191422) | Reference | ||||
Device | |||||
HORIZON TMS | |||||
Therapy System | |||||
with Navigation | |||||
(K183376) | Reference | ||||
Device | |||||
Nexstim | |||||
Navigational | |||||
Brain | |||||
Stimulation | |||||
(NBS) System 4, | |||||
Nexstim NBS | |||||
System 4 with | |||||
NEXSPEECH® | |||||
(K112881) | Discussion of comparison | ||||
Product Code, | |||||
Classification | HAW | ||||
(Subsequent: | |||||
GWF, IKN, OBP) | |||||
21 CFR | |||||
882.4560, | |||||
Class II | HAW | ||||
(Subsequent: | |||||
GWF, IKN, OBP) | |||||
21 CFR | |||||
882.4560, | |||||
Class II | OBP, HAW, IKN | ||||
21 CFR | |||||
882.5805, | |||||
Class II | GWF, HAW, | ||||
IKN | |||||
21 CFR | |||||
882.1870, | |||||
Class II | Classification of Subject Device, | ||||
Primary Predicate and Reference | |||||
Device matches. | |||||
The Subject Device is an | |||||
accessory to TMS therapy | |||||
systems, providing location for | |||||
the TMS coil. | |||||
Intended use | As an accessory | ||||
to TMS systems, | |||||
provide | |||||
navigation, | |||||
location support | |||||
for placement of | |||||
the TMS coil on | |||||
the skull in | |||||
relation to a prior | |||||
acquired MRI | |||||
image. | A | ||||
neuronavigation | |||||
system indicated | |||||
for accurate | |||||
positioning of the | |||||
treatment coil of | |||||
the CloudTMS | |||||
Therapy System | |||||
with respect to | |||||
target brain | |||||
regions based on | |||||
data obtained | |||||
from MRI | |||||
measurements. | A repetitive | ||||
transcranial | |||||
magnetic | |||||
stimulation | |||||
system that | |||||
delivers | |||||
transcranial | |||||
repetitive pulsed | |||||
magnetic fields of | |||||
sufficient | |||||
magnitude to | |||||
induce neural | |||||
action potentials | |||||
in the prefrontal | |||||
cortex to treat the | |||||
symptoms of | |||||
major depressive | Non-invasive | ||||
mapping of the | |||||
primary motor | |||||
cortex of the | |||||
brain to its | |||||
cortical gyrus. | |||||
The NBS System | |||||
provides | |||||
information that | |||||
may be used in | |||||
the assessment of | |||||
the primary motor | |||||
cortex for pre- | |||||
procedural | |||||
planning. | The intended use of Subject | ||||
Device, Primary Predicate and | |||||
both Reference Devices match | |||||
fully with regards to all aspects | |||||
related to effectiveness and safety | |||||
(navigation of a TMS coil relative | |||||
to MRI and/or scalp | |||||
landmarks/targets). | |||||
As accessory to the TMS system, | |||||
the device under review provides | |||||
TMS coil location support. | |||||
The device under review provides | |||||
a locating feature to TMS | |||||
systems. The device under review | |||||
is an optional accessory to | |||||
Substantial Equivalence Technical Characteristics | |||||
Feature | Subject Device | ||||
visor2 system | Primary | ||||
Predicate | |||||
Neural | |||||
Navigator | |||||
(K191422) | Reference | ||||
Device | |||||
HORIZON TMS | |||||
Therapy System | |||||
with Navigation | |||||
(K183376) | Reference | ||||
Device | |||||
Nexstim | |||||
Navigational | |||||
Brain | |||||
Stimulation | |||||
(NBS) System 4, | |||||
Nexstim NBS | |||||
System 4 with | |||||
NEXSPEECH® | |||||
(K112881) | Discussion of comparison | ||||
Indications | |||||
for Use | visor2 is used to | ||||
aid 3D navigation | |||||
for positioning of | |||||
Transcranial | |||||
Magnetic | |||||
Stimulation | |||||
(TMS) coils over | |||||
preselected brain | |||||
regions based on | |||||
data from MRI | |||||
measurements or | |||||
scalp landmarks | |||||
and optional | |||||
EMG recording | |||||
in or clinical | |||||
procedures. The | |||||
visor2 system is | |||||
compatible with | |||||
the following | |||||
commercially | |||||
available TMS | |||||
coils of the | |||||
following TMS | |||||
companies: | |||||
Mag & More: | |||||
PMD70-aCool | |||||
Double coil | |||||
MagStim | |||||
Company Ltd.: | |||||
Double 70mm | |||||
Remote Coil | |||||
(3190-00 rev2), | |||||
Double 70mm | |||||
Air Film | |||||
(3910-00) | |||||
MagVenture A/S: | |||||
Double 75mm | |||||
(C-B60), Double | |||||
Cooled 75mm | |||||
(Cool-B65), | The Neural | ||||
Navigator is a | |||||
neuronavigation | |||||
system indicated | |||||
for accurate | |||||
positioning of the | |||||
treatment coil of | |||||
the CloudTMS | |||||
Therapy System | |||||
with respect to | |||||
target brain | |||||
regions based on | |||||
data obtained | |||||
from MRI | |||||
measurements. | |||||
Specifically, the | |||||
Neural Navigator | |||||
is indicated for | |||||
use with the | |||||
following | |||||
CloudTMS | |||||
Therapy System | |||||
coils | |||||
manufactured by | |||||
Neurosoft Ltd: | |||||
AFEC-02-100 | |||||
and | |||||
AFEC-02-100-C. | HORIZON® is | ||||
indicated for the | |||||
treatment of | |||||
Major Depressive | |||||
Disorder in adult | |||||
patients who have | |||||
failed to achieve | |||||
satisfactory | |||||
improvement | |||||
from prior | |||||
antidepressant | |||||
medication in the | |||||
current episode. | The Nexstim | ||||
Navigated Brain | |||||
Stimulation | |||||
System (NBS | |||||
System) 4 is | |||||
indicated for non- | |||||
invasive mapping | |||||
of the primary | |||||
motor cortex of | |||||
the brain to its | |||||
cortical gyrus. | |||||
The NBS System | |||||
4 provides | |||||
information that | |||||
may be used in | |||||
the assessment of | |||||
the primary motor | |||||
cortex for | |||||
preprocedural | |||||
planning. | |||||
Nexstim | |||||
NEXSPEECH, | |||||
when used | |||||
together with the | |||||
Nexstim NBS | |||||
System 4, is | |||||
indicated for | |||||
noninvasive | |||||
localization of | |||||
cortical areas that | |||||
do not contain | |||||
essential speech | |||||
function. Nexstim | |||||
NEXSPEECH | |||||
provides | |||||
information that | |||||
may be used in | |||||
pre-surgical | |||||
planning in | |||||
patients | |||||
undergoing brain | |||||
surgery. | |||||
Intraoperatively, | |||||
the localization | |||||
information | |||||
provided by | The indication of use of Subject | ||||
Device, Primary Predicate and | |||||
both Reference Devices match | |||||
fully with regard to all aspects | |||||
related to effectiveness and safety | |||||
(navigation of a TMS coil relative | |||||
to MRI and/or scalp | |||||
landmarks/targets). The Subject | |||||
Device is more flexible with | |||||
regard to supported coils than any | |||||
of the Reference and Predicate | |||||
system. | |||||
As accessory to the TMS system, | |||||
the device under review provides | |||||
TMS coil location support. | |||||
The visor2 system under review is | |||||
an optional accessory to support | |||||
locating/navigating TMS coil | |||||
feature to existing TMS systems | |||||
for their intended use. | |||||
Note: | |||||
The reference device K183376 | |||||
HORIZON TMS Therapy System | |||||
with Navigation includes a | |||||
StimGuide feature to support | |||||
TMS coil location/navigation. | |||||
The StimGuide feature is a sub | |||||
licensed variation of the visor2 | |||||
system, was reviewed in the | |||||
Horizon TMS Therapy System | |||||
with Navigation, K183376, to | |||||
support TMS coil location. | |||||
Substantial Equivalence Technical Characteristics | |||||
Feature | Subject Device | ||||
visor2 system | Primary | ||||
Predicate | |||||
Neural | |||||
Navigator | |||||
(K191422) | Reference | ||||
Device | |||||
HORIZON TMS | |||||
Therapy System | |||||
with Navigation | |||||
(K183376) | Reference | ||||
Device | |||||
Nexstim | |||||
Navigational | |||||
Brain | |||||
Stimulation | |||||
(NBS) System 4, | |||||
Nexstim NBS | |||||
System 4 with | |||||
NEXSPEECH® | |||||
(K112881) | Discussion of comparison | ||||
Double 95mm | |||||
(D-B80), | |||||
Angulated | |||||
Double Cooled | |||||
97mm | |||||
(Cool-B70 rev2), | |||||
Butterfly figure-8 | |||||
(C-B70) | |||||
Neuronetics Inc.: | |||||
NeuroStar coil | |||||
The visor2 | |||||
system must be | |||||
operated by a | |||||
trained physician | |||||
and must not be | |||||
used during | |||||
surgical | |||||
operations. | NEXSPEECH® is | ||||
intended to be | |||||
verified by direct | |||||
cortical | |||||
stimulation. | |||||
The Nexstim | |||||
NBS System 4 | |||||
and NBS System | |||||
4 with | |||||
NEXSPEECH® | |||||
are not intended | |||||
to be used during | |||||
a surgical | |||||
procedure. The | |||||
Nexstim NBS | |||||
System 4 and | |||||
NBS System 4 | |||||
with | |||||
NEXSPEECH® | |||||
are intended to be | |||||
used by trained | |||||
clinical | |||||
professionals. | |||||
TMS Coil | |||||
Position | |||||
Principle | Based on | ||||
anatomy (MRI | |||||
picture) and | |||||
indirect targeting | |||||
of treatment | |||||
target through | |||||
measured | |||||
distance and | |||||
direction using | |||||
optical | |||||
stereotactic | |||||
navigation. | Based on | ||||
Anatomy (MRI | |||||
picture) and | |||||
electro-magnetic | |||||
field navigation. | Indirect targeting | ||||
of treatment | |||||
target through | |||||
measured | |||||
distance and | |||||
direction using | |||||
optical | |||||
stereotactic | |||||
navigation and | |||||
anatomy. | Based on | ||||
Anatomy (MRI | |||||
picture) and | |||||
optical | |||||
stereotactic | |||||
navigation. | All devices support the | ||||
location/navigation of the TMS | |||||
coil. The reference device | |||||
K183376 HORIZON TMS | |||||
Therapy System with Navigation | |||||
includes a StimGuide feature to | |||||
support TMS coil | |||||
location/navigation uses the same | |||||
methodology as the visor2 system | |||||
under review. | |||||
The StimGuide feature is a sub | |||||
licensed variation of the visor2 | |||||
system. | |||||
Subject Device, Primary Predicate | |||||
and both Reference Devices all | |||||
use the same or equivalent | |||||
position principle registering the | |||||
physical head/scalp and a coil via | |||||
tracker tools tracked by a stereo | |||||
infrared camera 3D tracking | |||||
system or in case of the Primary | |||||
Predicate Device electro-magnetic | |||||
field tracking. Electro-magnetic | |||||
Substantial Equivalence Technical Characteristics | |||||
Feature | Subject Device | ||||
visor2 system | Primary | ||||
Predicate | |||||
Neural | |||||
Navigator | |||||
(K191422) | Reference | ||||
Device | |||||
HORIZON TMS | |||||
Therapy System | |||||
with Navigation | |||||
(K183376) | Reference | ||||
Device | |||||
Nexstim | |||||
Navigational | |||||
Brain | |||||
Stimulation | |||||
(NBS) System 4, | |||||
Nexstim NBS | |||||
System 4 with | |||||
NEXSPEECH® | |||||
(K112881) | Discussion of comparison | ||||
Fundamental | Infrared locators | ||||
and 3D tracking | Electro-magnetic | ||||
field tracking | Infrared locators | ||||
and 3D tracking | Infrared locators | ||||
and camera | field tracking and optical field | ||||
tracking are both relying on | |||||
identifying the position of tools in | |||||
3D space. Optical tracking is in | |||||
general more precise as it relies | |||||
on shorter wavelength than | |||||
electrical tracking. All devices | |||||
define targets either via | |||||
landmarks in a co-registered MRI | |||||
image (same principle in all | |||||
systems using nasion-ear | |||||
landmarks) or directly on the | |||||
scalp. Further, all devices define a | |||||
point that represents the centre | |||||
position of the coil for navigation. | |||||
This is either referred to as a | |||||
geometrical centre of the coil | |||||
defining the maximum of the field | |||||
simply by geometry of the coil or | |||||
referring to the electrical field | |||||
maximum by design for any | |||||
treatment coil including tilted | |||||
designs. This point is at the | |||||
geometric centre of the coil and as | |||||
close as possible to the scalp | |||||
surface. The display of any | |||||
modelled induced electrical field | |||||
in the head tissue does not impact | |||||
the accuracy of the stimulus | |||||
delivered relative to the target but | |||||
only illustrates the field | |||||
distribution of a TMS stimulus | |||||
induced in head tissue. The | |||||
Primary Predicate device as well | |||||
as the Subject Device and the | |||||
Horizon Reference device rely on | |||||
geometry directly for the defining | |||||
the stimulation centre point while | |||||
reference K112881 calculates an | |||||
E-field for this purpose. With | |||||
regard to effectiveness and safety | |||||
all devices follow the same | |||||
working principle and perform | |||||
with identical effectiveness. The | |||||
Subject Device does not impose | |||||
any new or additional safety risks. | |||||
Comparison and discussion for | |||||
Substantial Equivalence Technical Characteristics | |||||
Feature | Subject Device | ||||
visor2 system | Primary | ||||
Predicate | |||||
Neural | |||||
Navigator | |||||
(K191422) | Reference | ||||
Device | |||||
HORIZON TMS | |||||
Therapy System | |||||
with Navigation | |||||
(K183376) | Reference | ||||
Device | |||||
Nexstim | |||||
Navigational | |||||
Brain | |||||
Stimulation | |||||
(NBS) System 4, | |||||
Nexstim NBS | |||||
System 4 with | |||||
NEXSPEECH® | |||||
(K112881) | Discussion of comparison | ||||
for locating | |||||
TMS coil | |||||
location | |||||
with regard to | |||||
prior acquired | |||||
MRI images | infrared camera | ||||
technology for | |||||
land-marking to | |||||
facial and skull | |||||
features using | |||||
tracking tools. | using tracking | ||||
tools. | infrared camera | ||||
technology for | |||||
land-marking to | |||||
facial and skull | |||||
features using | |||||
tracking tools. | technology for | ||||
land-marking to | |||||
facial and skull | |||||
feature using | |||||
tracking tools. | |||||
Electric field | |||||
calculation used | |||||
to visualize an | |||||
estimated field | |||||
generated by the | |||||
TMS coil. | position principle". All | ||||
systems/devices except Primary | |||||
Predicate use the same stereo | |||||
infrared 3D camera tracking | |||||
principle (and same supplier for | |||||
this component) to track tools | |||||
attached to the TMS coil and the | |||||
head in space. The predicate | |||||
device uses electro-magnetic field | |||||
tracking with similar accuracy. | |||||
All systems except the Horizon | |||||
Reference co-register an MRI | |||||
image with the physical head | |||||
using nasion, left and right | |||||
preauricular points on the head | |||||
and in the MRI image (or only on | |||||
the head if individual MRI is not | |||||
used). The induced electrical field | |||||
of the coil is used in K112881 to | |||||
represent the modelled field | |||||
maximum while the Primary | |||||
Predicate, the Subject Device, and | |||||
the Reference device K183376 | |||||
uses the coil geometry that give | |||||
equivalent results. The Subject | |||||
Device allows the user to | |||||
optionally show the induced | |||||
electrical field and align the field | |||||
maximum with the targeted | |||||
location. With regard to | |||||
effectiveness and safety, all | |||||
devices use the same principle | |||||
and perform identically. | |||||
Main | |||||
Components | All-In-One | ||||
computer: | |||||
User | |||||
interface, | |||||
Isolation | |||||
Transformer | |||||
For TMS Coil | |||||
location support: | |||||
3D Tracking | |||||
subsystem | |||||
(Stereotactic | |||||
camera | |||||
positioning | |||||
system), | 3D Tracking | ||||
subsystem | |||||
Head band for | |||||
TMS coil | |||||
location/Navigati | |||||
on | HORIZON® | ||||
TMS Therapy | |||||
System | |||||
a. HORIZON® | |||||
User | |||||
Interface; | |||||
b. HORIZON® | |||||
Mainframe; | |||||
c. HORIZON® | |||||
Power | |||||
Supply; | |||||
d. HORIZON® | |||||
MT Remote | |||||
Coil; | 3D Tracking | ||||
subsystem | |||||
a. Mobile | |||||
Nexstim cart | |||||
b. Nexstim TMS | |||||
stimulator | |||||
c. Nexstim | |||||
stimulation | |||||
coil | |||||
d. Stereotactic | |||||
camera (arm- | |||||
mounted | |||||
tracking unit) | Both the visor2 system and | ||||
primary predicate are cart based | |||||
systems that substantially consist | |||||
of a computer based navigation | |||||
system and navigation tools and | |||||
accessories. | |||||
The reference device K183376 | |||||
HORIZON TMS Therapy System | |||||
with Navigation includes a | |||||
StimGuide feature to support | |||||
TMS coil location/navigation. | |||||
The StimGuide feature is a sub | |||||
licensed variation of the visor2 | |||||
system. The same TMS coil | |||||
navigation components are | |||||
Substantial Equivalence Technical Characteristics | |||||
Feature | Subject Device | ||||
visor2 system | Primary | ||||
Predicate | |||||
Neural | |||||
Navigator | |||||
(K191422) | Reference | ||||
Device | |||||
HORIZON TMS | |||||
Therapy System | |||||
with Navigation | |||||
(K183376) | Reference | ||||
Device | |||||
Nexstim | |||||
Navigational | |||||
Brain | |||||
Stimulation | |||||
(NBS) System 4, | |||||
Nexstim NBS | |||||
System 4 with | |||||
NEXSPEECH® | |||||
(K112881) | Discussion of comparison | ||||
board, | |||||
Reference | |||||
tracking tool, | |||||
Pointer tool, | |||||
Coil tracker | |||||
visor2 cart | |||||
eego amplifier, | |||||
EE-410 | |||||
(for optional | |||||
EMG acquisition) | e. HORIZON® E- | ||||
z Cool Coil | |||||
W/StimGuide | |||||
Tracking | |||||
Reference ('E- | |||||
z Cool Coil | |||||
(SG)'); | |||||
f. HORIZON® E- | |||||
z Cart and | |||||
Arm | |||||
StimGuide | |||||
Accessories: | |||||
a. Interconnecting | |||||
Cables; | |||||
b. Footswitch; | |||||
c. Pointer Tool; | |||||
d. Head | |||||
Reference. | |||||
e. eego amplifier, | |||||
EE-410 | |||||
(for optional | |||||
EMG | |||||
acquisition) | e. 6-channel | ||||
Nexstim EMG | |||||
f. NBS computer | |||||
system with | |||||
dual 23” | |||||
displays, PC | |||||
and NBS | |||||
software | |||||
g. Three-pedal | |||||
foot switch | |||||
h. Nexstim | |||||
cooling unit | |||||
(optional) | |||||
i. Electronically- | |||||
adjustable | |||||
patient chair | |||||
j. System also | |||||
includes | |||||
tracking tools: | |||||
NBS head | |||||
tracker, | |||||
coil tracker, | |||||
and | |||||
digitizing pen | applied in this reference device as | ||||
applied in the visor2 system | |||||
Software | |||||
Controlled | Yes | Yes | Yes | Yes | All devices rely on software for |
user interface and applicable | |||||
functions. The interfaces are very | |||||
similar and use workflow panels | |||||
combined with 3D render views. | |||||
Software | |||||
operates on a | |||||
personal | |||||
computer | |||||
(PC) | Yes | Yes | Yes | Unknown | All devices use a very similar |
deployment environment on | |||||
standard medical compliant | |||||
computers. | |||||
Software | |||||
Level of | |||||
Concern | Moderate | Unknown | Moderate | Unknown | Both the visor2 system under |
review and the reference device | |||||
K183376 HORIZON TMS | |||||
Therapy System with Navigation | |||||
by the StimGuide feature have a | |||||
moderate software level concern. | |||||
Other devices are equivalently | |||||
rated. | |||||
Prescription | |||||
Only | Yes | Yes | Yes | Yes | All devices are prescription only |
devices for use by medical | |||||
professionals. | |||||
Substantial Equivalence Technical Characteristics | |||||
Feature | Subject Device | ||||
visor2 system | Primary | ||||
Predicate | |||||
Neural | |||||
Navigator | |||||
(K191422) | Reference | ||||
Device | |||||
HORIZON TMS | |||||
Therapy System | |||||
with Navigation | |||||
(K183376) | Reference | ||||
Device | |||||
Nexstim | |||||
Navigational | |||||
Brain | |||||
Stimulation | |||||
(NBS) System 4, | |||||
Nexstim NBS | |||||
System 4 with | |||||
NEXSPEECH® | |||||
(K112881) | Discussion of comparison | ||||
TMS Coil | |||||
Positioning | |||||
Feature | Visor2 system | ||||
Applies | |||||
commercially | |||||
available Polaris | |||||
tracking system | |||||
from Northern | |||||
Digital Inc. | BrainTRAK | ||||
Applies electro- | |||||
magnetic tracking | StimGuide | ||||
feature | |||||
Applies | |||||
commercially | |||||
available Polaris | |||||
tracking system | |||||
from Northern | |||||
Digital Inc. | Nexstim NBS | ||||
Applies | |||||
commercially | |||||
available Polaris | |||||
tracking system | |||||
from Northern | |||||
Digital Inc. | All devices except Primary | ||||
Predicate apply the same tracking | |||||
technology. |
The optical and electro-magnetic
tracking principle are both relying
on fields that are received either
by infrared sensors for optical
tracking or by receiver arrays for
the electro-magnetic case. These
fields are analyzed via tracking
tools in 3D space.
Both principles are equivalent and
do not differ in effectiveness or
safety aspects. |
| TMS Coil
Navigation
Patient
Contacting
Components | Tracking
Reference
Pointer Tool
EMG sticker
Electrodes
(Commercially
available) | Head strap(s) | Tracking
Reference
Pointer Tool
EMG Electrodes
(Commercially
available) | NBS head tracker
Digitizing pen
EMG Electrodes
(Commercially
available) | Compared to the predicate the
visor2 system supports physical
anatomical land marking and
fixation of the Tracking reference
to the head by sticker electrodes
whereas the predicate applies a
head strap.
Using adhesive stickers in the
Subject device instead of the head
band can reduce risks for shifts of
the tracker tool compared to the
Predicate Device and will thus
have the same or better
effectiveness and safety. |
| Duration of
TMS Coil
tracking
patient
contact |